High-Throughput Genomic Analysis in Waldenström's Macroglobulinemia
- 1 February 2011
- journal article
- review article
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 11 (1), 106-108
- https://doi.org/10.3816/clml.2011.n.021
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Application of array‐based whole genome scanning technologies as a cytogenetic tool in haematological malignanciesBritish Journal of Haematology, 2009
- The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathologyTrends in Immunology, 2009
- Identification of Copy Number Abnormalities and Inactivating Mutations in Two Negative Regulators of Nuclear Factor-κB Signaling Pathways in Waldenström's MacroglobulinemiaCancer Research, 2009
- Analysis of 6q deletion in Waldenstrom macroglobulinemiaEuropean Journal of Haematology, 2007
- Waldenström macroglobulinemiaBlood, 2007
- 6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosisBritish Journal of Haematology, 2006
- 6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significanceCancer Genetics and Cytogenetics, 2006
- Trisomy 4, a new chromosomal abnormality in Waldenström's macroglobulinemia: a study of 39 casesLeukemia, 2006
- Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003
- Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletionsBlood, 2002